好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Characterization of Misdiagnosed and Undiagnosed Huntington’s Disease (HD) Patients and Family Members at UCLA
Movement Disorders
P2 - Poster Session 2 (11:45 AM-12:45 PM)
16-015

To describe characteristics of persons with HD seen at UCLA’s Huntington’s Disease Society of America (HDSA) Center of Excellence (COE) who experienced misdiagnosis of HD symptoms and who had misdiagnosed and/or undiagnosed family members.

Huntington’s Disease (HD) is a rare neurodegenerative condition with psychiatric and cognitive symptoms, which may predate the classic chorea presentation. This may lead to misdiagnosis with other psychiatric and/or neurodegenerative conditions.

We conducted a chart review of 344 HD persons seen at UCLA between January 2012 and December 2021. One RA reviewed clinical notes from patients’ first visits and collected data on a) patient misdiagnosis and b) family members who were misdiagnosed or undiagnosed and likely had HD, as determined by patient narratives describing their symptoms and their family history. Another RA verified the data. An expert clinician resolved disagreements. Descriptive statistics were used to characterize patients and family members who were misdiagnosed and/or undiagnosed.

Only 18 patients were misdiagnosed, and 78 patients had family members who were misdiagnosed or undiagnosed. Of the misdiagnosed patients, 17 received a diagnosis before being seen at UCLA. Cognitive/behavioral and movement disorders, such as schizophrenia and tics, respectively, were the most common misdiagnoses among both patients and family members. Among family members who never received a formal clinical diagnosis, the most common set of symptom descriptions included “uncontrolled movements.”

Misdiagnoses among HD patients at UCLA were rare. We suspect this is due to patient referral bias, with individuals with a known HD diagnosis being referred to UCLA. Studies on misdiagnosis and interventions to improve HD recognition should focus on pre-COE points of care, including primary care and general neurology clinics.

Authors/Disclosures
Lina Shammas, Student
PRESENTER
Ms. Shammas has received personal compensation for serving as an employee of Arrowhead Pharmaceuticals. Ms. Shammas has received personal compensation for serving as an employee of Architect Therapeutics.
Mariann A. Tobar Ms. Tobar has nothing to disclose.
Derrick N. Okine, BA Mr. Okine has nothing to disclose.
Paola Perez, BS Miss Perez has nothing to disclose.
Adys Mendizabal, MD, MS (UCLA) Dr. Mendizabal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Clinical 好色先生 Alliance. Dr. Mendizabal has received research support from Huntington's Disease Society of America. Dr. Mendizabal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Huntington's Disease Society of America (HDSA).